Fintel reports that on July 14, 2025, BTIG downgraded their outlook for TechnipFMC (NYSE:FTI) from Buy to Neutral. Analyst ...

Fintel reports that on July 14, 2025, BTIG upgraded their outlook for Synchrony Financial (NYSE:SYF) from Neutral to Buy.

Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat ...

As of Monday, the S&P 500 has been trading above its 20-day moving average for 55 days. That's the longest stretch since ...

BTIG downgraded shares of Affirm and PROG Holdings ahead of second-quarter earnings, flagging concerns over weakening credit trends and increased competition from traditional lenders. Brokerage ...

BTIG downgraded AFRM to "neutral" from "buy" Though shares of buy-now-pay-later name Affirm Holdings Inc (NASDAQ:AFRM) have ...

Billionaire Kerr Neilson has bought over $8 million worth of shares in Flutter Entertainment plc (NYSE:FLUT), representing ...

Brokerage firm BTIG LLC accused StoneX Group Inc., a rival brokerage and investment bank, of stealing its proprietary software code in what its lawyers describe as “one of the greatest financial ...

Detailed price information for Cloudflare Inc Cl A (NET-N) from The Globe and Mail including charting and trades.

BTIG analyst Jeet Mukherjee initiated coverage of Arvinas (ARVN) with a Buy rating and $69 price target The company’s lead program, vepdegestrant, is a potent ER degrader for being developed for ...

BTIG sees increased stability for the medtech sector in 2024, helped by election year dynamics, as it makes its top stock picks for the coming year. Read more here.